Oz Azam, Empyrean Neuroscience CEO

Where CAR-Ts were in 2012? For­mer Tmu­ni­ty CEO Oz Azam un­veils not-quite-a-psy­che­delics biotech

In Feb­ru­ary, Oz Azam left Tmu­ni­ty months af­ter its cell ther­a­py pro­gram came to a screech­ing halt fol­low­ing two pa­tient deaths. At the time …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.